证券代码：603955 证券简称：大千生态 公告编号：2025-053 大千生态环境集团股份有限公司 报告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性承担个别及连带责任。 根据上海证券交易所印发的《上海证券交易所上市公司自律监管指引第 1 号——规范运作》及相关格式指引的规定，大千生态环境集团股份有限公司（以 下简称"公司"）董事会将公司 2025 年半年度募集资金存放与实际使用情况专 项报告如下： 一、募集资金基本情况 （一）实际募集资金金额及资金到账时间 经中国证券监督管理委员会《关于核准大千生态环境集团股份有限公司非公 开发行股票的批复》（证监许可〔2019〕1570 号）核准，公司非公开发行不超 过 22,620,000 股新股，每股发行价格为 13.46 元，募集资金总额 304,465,200.00 元，扣除发行费用 5,273,205.66 元（不含增值税）后，实际募集资金净额为 会计师事务所（特殊普通合伙）审验，并出具天衡验字（2020）00042 号《验资 报告》。 （二）半年度使用金额及当前余额 截至 2025 年 ...

Fundraising Overview - The company completed a non-public offering of 215,373,741 shares at a price of RMB 3.86 per share, raising a total of RMB 818,524,331.34 [1] - The funds were received on January 20, 2022, and were verified by Da Hua Accounting Firm [1] Fund Management and Usage - The company established dedicated accounts for the management of the raised funds, signing agreements with the sponsor, CITIC Securities, and various banks to ensure the safety of the funds [2] - As of the announcement date, all raised funds have been fully utilized, with a minimal remaining balance representing interest, approximately 0.00016% of the net amount raised [2] Account Closure - The company has completed the closure of the dedicated fundraising accounts, transferring the remaining balance of RMB 1,292.38 to other bank accounts for permanent working capital [2][3] - The closure of the accounts also terminates the related agreements with the sponsor and banks [3]

Fundraising Overview - Guodi Technology Co., Ltd. has successfully raised a total of RMB 467,804,160.00 by issuing 165,888,000 shares at a price of RMB 2.82 per share, with a net amount of RMB 459,265,712.30 after deducting related expenses [1][2]. Fund Management - The company has established a fundraising management system in compliance with relevant laws and regulations to ensure the proper use of raised funds and protect investor interests [2]. - A tripartite supervision agreement has been signed with Zheshang Securities Co., Ltd. and CITIC Bank Foshan Branch to ensure strict approval procedures for the use of raised funds [2]. Account Closure - The fundraising special account has been closed as the funds have been used in accordance with regulations, and the corresponding tripartite supervision agreement has been terminated [2][3].

截至2025年5月30日收盘，维力医疗（603309）报收于12.07元，较上周的12.28元下跌1.71%。本周，维 力医疗5月28日盘中最高价报12.45元。5月29日盘中最低价报11.83元。维力医疗当前最新总市值35.35亿 元，在医疗器械板块市值排名90/126，在两市A股市值排名3758/5146。 本周关注点 维力医疗关于募集资金使用完毕并注销募集资金专户的公告 广州维力医疗器械股份有限公司发布公告，宣布2021年非公开发行股票募集资金已按规定全部使用完 毕，所有募集资金专户均已注销。公司非公开发行人民币普通股29632218股，发行价格每股13.48元， 募集资金总额为399442298.64元，净额为392814940.16元。募集资金到位情况由华兴会计师事务所审 验。 公司根据相关法律法规制定了《维力医疗募集资金管理制度》，开设了募集资金专项账户，并与开户银 行及保荐机构中信证券签订了监管协议，确保募集资金专款专用。募集资金专项账户分别用于营销中心 建设项目、一次性使用合金涂层抗感染导尿管生产建设项目、研发中心建设项目和血液净化体外循环管 路生产扩建项目，这些账户现已全部注销。 其中，研发 ...